DDW is delighted to announce that Carleen Klumpp-Thomas, MS, Deputy Director, Research Services Core, Director, Automation, National Center for Advancing Translational Sciences (NCATS), will be speaking at DDW‘s track – Concept to Cure: Curiosity and Lab Automation in Drug Discovery at SLAS2025 (25-29 January 2025, San Diego, USA).

This free programme, which will run on 27, 28 and 29 January, will present examples of research and drug development from industry experts using lab automation and technology.

Klumpp-Thomas will be speaking on: Curiosity unleashed: Cat-ivating innovation through robotics and automation in drug discovery. It will take place in the Ignite Theater on 29 January.

Klumpp-Thomas is an automation engineering expert with 19 years at NCATS and who manages dynamic robotic platforms for diverse pre-clinical experimentation. She excels in advanced technologies, fosters collaboration, and along with her teams, extends automation beyond high-throughput screening operations to chemistry synthesis and sustainability, ensuring NCATS remains at the forefront of scientific research.

Speaker line-up:

• Dr Raminderpal Singh, 20/15 Visioneers 27 January
• Nicola Richmond, Expert in AI and lab technologies in drug discovery 27 January
• Graham T. Dempsey, Quiver Biosciences 28 January
• Fatah Kashanchi, George Mason University and Heather Branscome, ATCC 28 January
• Alexander G. Godfrey, National Center for Advancing Translational Sciences (NCATS) 28 January
• Carleen Klumpp-Thomas, National Center for Advancing Translational Sciences (NCATS) 29 January

The track is sponsored by ATCC, Integra Biosciences, Collaborative Drug Discovery (CDD) and Tecan.

Register your interest here.